Cyprotex Plc
MACCLESFIELD, England, December 7, 2010 - Cyprotex (LSE:CRX), the preclinical ADME Tox services company, announces
the successful cross validation of the CellCiphr(TM) cytotoxicity panels and
their official relaunch as a Cyprotex service.
MACCLESFIELD, England, August 20, 2010 - Cyprotex PLC (LSE:CRX), the preclinical ADME Tox services company, today
announces the launch of its new in vitro toxicology service, branded as
Cyprotox(R).
